Minerva Neurosciences (NERV) Total Debt (2014 - 2017)

Minerva Neurosciences' Total Debt history runs 4 years deep, the most recent figure standing at $1.3 million for Q2 2017.

• Quarterly Total Debt fell 78.69% year-over-year to $1.3 million in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $1.3 million (down 78.69% YoY) and the FY2016 annual result came in at $3.8 million, down 54.83% from the prior year.
• Total Debt was $1.3 million for Q2 2017 at Minerva Neurosciences, down from $2.6 million in the prior quarter.
• Across five years, Total Debt topped out at $9.6 million in Q3 2015 and bottomed at $1.3 million in Q2 2017.
• A 4-year average of $5.8 million and a median of $6.2 million in 2016 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2015 — Total Debt soared 528.92% — and 2017, when it slumped 78.69%.
• Minerva Neurosciences' Total Debt stood at $1.4 million in 2014, then surged by 514.91% to $8.5 million in 2015, then tumbled by 54.83% to $3.8 million in 2016, then slumped by 65.47% to $1.3 million in 2017.
• Business Quant data shows NERV's Total Debt at $1.3 million in Q2 2017, $2.6 million in Q1 2017, and $3.8 million in Q4 2016.